A perspective on autophagy and transcription factor EB in Alcohol-Associated Alzheimer's disease

Biochem Pharmacol. 2023 Jul:213:115576. doi: 10.1016/j.bcp.2023.115576. Epub 2023 Apr 29.

Abstract

Alzheimer's disease (AD) is the most common form of progressive dementia and there is no truly efficacious treatment. Accumulating evidence indicates that impaired autophagic function for removal of damaged mitochondria and protein aggregates such as amyloid and tau protein aggregates may contribute to the pathogenesis of AD. Epidemiologic studies have implicated alcohol abuse in promoting AD, yet the underlying mechanisms are poorly understood. In this review, we discuss mechanisms of selective autophagy for mitochondria and protein aggregates and how these mechanisms are impaired by aging and alcohol consumption. We also discuss potential genetic and pharmacological approaches for targeting autophagy/mitophagy, as well as lysosomal and mitochondrial biogenesis, for the potential prevention and treatment of AD.

Keywords: Aggrephagy; Mitochondria; Mitophagy; NAD; TFEB.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Autophagy
  • Ethanol
  • Humans
  • Mitophagy / genetics
  • Protein Aggregates
  • Transcription Factors

Substances

  • Protein Aggregates
  • Ethanol
  • Transcription Factors
  • Amyloid beta-Peptides